Sarpogrelate
- Generic Name
- Sarpogrelate
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C24H31NO6
- CAS Number
- 125926-17-2
- Unique Ingredient Identifier
- 19P708E787
- Background
Sarpogrelate has been investigated for the treatment of Diabetes Mellitus, Diabetic Nephropathy, Coronary Artery Disease, and Renal Insufficiency, Chronic.
- Indication
用于改善慢性动脉闭塞症所引起的溃疡、疼痛及冷感等缺血性症状。
- Associated Conditions
- -
- Associated Therapies
- -
The Prevention of Contrast Induced Nephropathy by Sarpogrelate in Patients With Chronic Kidney Disease
- First Posted Date
- 2010-07-20
- Last Posted Date
- 2010-07-20
- Lead Sponsor
- Seoul National University Boramae Hospital
- Target Recruit Count
- 212
- Registration Number
- NCT01165567
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath